NEMERA offers off-the-shelf nasal spray devices with in-vitro bioequivalence (IVBE) performance

NEMERA NEWS

NEMERA offers off-the-shelf nasal spray devices with in-vitro bioequivalence (IVBE) performance

Nemera has developed customized delivery systems with in-vitro bioequivalence performance for the following drugs:in-vitro bioequivalence Nemera

Those customized devices are based on SP270+ pump platform technology, and Nemera has performed a comparative analysis and related use human factor studies.

  • SP270+ pumps
  • Nasal actuator
  • Cap

Nemera IVBE

Example of SP270+ crimp-on (20mm) and nasal actuator, a reference in consistency and reliability

With spray expertise, regulatory experts and laboratory testing capabilities, Nemera is able to support your development by performing screening testing with your formulation following the EMA and FDA requirements.

For further information about the Nemera Device Equivalence program,
please contact us at: pascale.farjas@nemera.net